Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-01-08
2009-10-06
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S237500, C514S255060, C514S350000, C544S097000, C544S175000, C544S406000, C546S253000
Reexamination Certificate
active
07598241
ABSTRACT:
Novel compounds of the formula (I) in which R1, D, X, W, Y and T have the meaning indicated in Patent Claim (1), e.g. (II), are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
REFERENCES:
patent: 7183277 (2007-02-01), Dorsch et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: WO 02/48099 (2002-06-01), None
patent: WO 02/074735 (2002-09-01), None
patent: WO 02/083630 (2002-10-01), None
patent: WO 03/093235 (2003-11-01), None
Stella, Valentino J, Expert Opinion of Therapeutic Patents, Prodrugs as therapeutics, 2004 14(3): 277-280.
Wolff et al. (Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994).
Testa, Bernard, Biochemical Pharmacology, Prodrug Research: futile or fertile? 68 (2004) 2097-2106.
Ettmayer, Peter, Medicinal Chemistry, Lessons Learned from Marketed and Investigational Prodrugs, 47(10) (2004) 2394-2404.
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al., abstract, Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Tsaklakidis Christos
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
Carboxamide derivatives and their use as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxamide derivatives and their use as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxamide derivatives and their use as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087636